Which closed-end funds own Nanjing Leads Biolabs Co. Ltd.?
1 active closed-end fund report this security in their latest N-PORT filing, with a combined reported value of $2.1M. Security type: common equity. Country: China. ISIN CNE1000070H8 · ticker 9887.HK.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| TDF Templeton Dragon Fund | U.S. Equity | 0.64% | $2.1M | 329,085 sh | $326M | 17.1% discount | Jun 30, 2026 |
1 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “9887.HK” → · Compare two funds’ portfolios →